Annual EBIT
$126.40 M
-$58.36 M-31.59%
December 31, 2023
Summary
- As of February 7, 2025, MED annual earnings before interest & taxes is $126.40 million, with the most recent change of -$58.36 million (-31.59%) on December 31, 2023.
- During the last 3 years, MED annual EBIT has fallen by -$7.76 million (-5.78%).
- MED annual EBIT is now -41.55% below its all-time high of $216.24 million, reached on December 31, 2021.
Performance
MED EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
$2.11 M
+$9.98 M+126.74%
September 30, 2024
Summary
- As of February 7, 2025, MED quarterly earnings before interest & taxes is $2.11 million, with the most recent change of +$9.98 million (+126.74%) on September 30, 2024.
- Over the past year, MED quarterly EBIT has increased by +$9.98 million (+126.74%).
- MED quarterly EBIT is now -96.57% below its all-time high of $61.41 million, reached on June 30, 2021.
Performance
MED Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
$10.85 M
-$23.40 M-68.33%
September 30, 2024
Summary
- As of February 7, 2025, MED TTM earnings before interest & taxes is $10.85 million, with the most recent change of -$23.40 million (-68.33%) on September 30, 2024.
- Over the past year, MED TTM EBIT has dropped by -$23.40 million (-68.33%).
- MED TTM EBIT is now -95.04% below its all-time high of $218.49 million, reached on March 31, 2022.
Performance
MED TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
MED EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -31.6% | +126.7% | -68.3% |
| 3 y3 years | -5.8% | -96.2% | -94.8% |
| 5 y5 years | +83.0% | -89.6% | -88.1% |
MED EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -41.5% | at low | -96.2% | +126.7% | -95.0% | at low |
| 5 y | 5-year | -41.5% | +38.8% | -96.6% | +126.7% | -95.0% | at low |
| alltime | all time | -41.5% | +4128.1% | -96.6% | +126.7% | -95.0% | +2388.2% |
Medifast EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.11 M(-126.7%) | $10.85 M(-68.3%) |
| Jun 2024 | - | -$7.88 M(-199.2%) | $34.25 M(-57.6%) |
| Mar 2024 | - | $7.94 M(-8.5%) | $80.83 M(-36.1%) |
| Dec 2023 | $126.40 M(-31.6%) | $8.68 M(-66.0%) | $126.40 M(-15.9%) |
| Sep 2023 | - | $25.51 M(-34.1%) | $150.28 M(-13.1%) |
| Jun 2023 | - | $38.71 M(-27.7%) | $172.93 M(-5.6%) |
| Mar 2023 | - | $53.51 M(+64.4%) | $183.18 M(-0.8%) |
| Dec 2022 | $184.76 M(-14.6%) | $32.55 M(-32.4%) | $184.74 M(-7.1%) |
| Sep 2022 | - | $48.16 M(-1.7%) | $198.92 M(-3.5%) |
| Jun 2022 | - | $48.96 M(-11.1%) | $206.05 M(-5.7%) |
| Mar 2022 | - | $55.07 M(+17.9%) | $218.49 M(+1.1%) |
| Dec 2021 | $216.24 M(+61.2%) | $46.73 M(-15.5%) | $216.22 M(+4.2%) |
| Sep 2021 | - | $55.29 M(-10.0%) | $207.47 M(+5.5%) |
| Jun 2021 | - | $61.41 M(+16.3%) | $196.74 M(+20.4%) |
| Mar 2021 | - | $52.80 M(+39.1%) | $163.43 M(+21.8%) |
| Dec 2020 | $134.16 M(+47.4%) | $37.97 M(-14.8%) | $134.16 M(+16.8%) |
| Sep 2020 | - | $44.56 M(+58.6%) | $114.90 M(+26.8%) |
| Jun 2020 | - | $28.10 M(+19.4%) | $90.60 M(+0.8%) |
| Mar 2020 | - | $23.53 M(+25.8%) | $89.86 M(-1.3%) |
| Dec 2019 | $91.04 M(+31.8%) | $18.71 M(-7.7%) | $91.04 M(-1.2%) |
| Sep 2019 | - | $20.26 M(-25.9%) | $92.14 M(+3.1%) |
| Jun 2019 | - | $27.36 M(+10.7%) | $89.34 M(+13.0%) |
| Mar 2019 | - | $24.71 M(+24.8%) | $79.09 M(+14.5%) |
| Dec 2018 | $69.06 M(+74.3%) | $19.80 M(+13.4%) | $69.06 M(+17.6%) |
| Sep 2018 | - | $17.47 M(+2.1%) | $58.75 M(+14.1%) |
| Jun 2018 | - | $17.11 M(+16.5%) | $51.51 M(+12.7%) |
| Mar 2018 | - | $14.68 M(+54.8%) | $45.71 M(+15.3%) |
| Dec 2017 | $39.63 M(+47.6%) | $9.49 M(-7.2%) | $39.63 M(+7.8%) |
| Sep 2017 | - | $10.23 M(-9.6%) | $36.76 M(+3.6%) |
| Jun 2017 | - | $11.31 M(+31.4%) | $35.49 M(+21.5%) |
| Mar 2017 | - | $8.61 M(+30.2%) | $29.20 M(+8.7%) |
| Dec 2016 | $26.86 M(-6.4%) | $6.61 M(-26.1%) | $26.86 M(+4.2%) |
| Sep 2016 | - | $8.95 M(+78.2%) | $25.78 M(+3.9%) |
| Jun 2016 | - | $5.02 M(-19.8%) | $24.80 M(-12.8%) |
| Mar 2016 | - | $6.27 M(+13.3%) | $28.44 M(-0.9%) |
| Dec 2015 | $28.68 M(-5.2%) | $5.53 M(-30.6%) | $28.68 M(+4.9%) |
| Sep 2015 | - | $7.97 M(-7.9%) | $27.33 M(+5.3%) |
| Jun 2015 | - | $8.66 M(+33.0%) | $25.95 M(-4.4%) |
| Mar 2015 | - | $6.51 M(+55.6%) | $27.15 M(-10.2%) |
| Dec 2014 | $30.25 M(-21.3%) | $4.18 M(-36.5%) | $30.25 M(-20.2%) |
| Sep 2014 | - | $6.59 M(-33.2%) | $37.90 M(-2.0%) |
| Jun 2014 | - | $9.86 M(+2.6%) | $38.66 M(-2.0%) |
| Mar 2014 | - | $9.61 M(-18.8%) | $39.44 M(+2.7%) |
| Dec 2013 | $38.41 M(+41.5%) | $11.84 M(+61.1%) | $38.41 M(+12.8%) |
| Sep 2013 | - | $7.35 M(-30.9%) | $34.05 M(-4.4%) |
| Jun 2013 | - | $10.64 M(+24.0%) | $35.62 M(+20.4%) |
| Mar 2013 | - | $8.58 M(+14.7%) | $29.58 M(+9.0%) |
| Dec 2012 | $27.14 M(-0.9%) | $7.48 M(-16.3%) | $27.14 M(+28.2%) |
| Sep 2012 | - | $8.93 M(+94.2%) | $21.17 M(+11.7%) |
| Jun 2012 | - | $4.60 M(-25.1%) | $18.96 M(-19.0%) |
| Mar 2012 | - | $6.14 M(+306.2%) | $23.41 M(-14.5%) |
| Dec 2011 | $27.38 M | $1.51 M(-77.5%) | $27.38 M(-11.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2011 | - | $6.71 M(-25.9%) | $31.00 M(-7.0%) |
| Jun 2011 | - | $9.06 M(-10.4%) | $33.34 M(-0.6%) |
| Mar 2011 | - | $10.10 M(+96.7%) | $33.54 M(+6.0%) |
| Dec 2010 | $31.64 M(+70.4%) | $5.13 M(-43.2%) | $31.64 M(+3.0%) |
| Sep 2010 | - | $9.05 M(-2.2%) | $30.71 M(+12.8%) |
| Jun 2010 | - | $9.26 M(+12.9%) | $27.22 M(+19.6%) |
| Mar 2010 | - | $8.20 M(+95.1%) | $22.75 M(+22.5%) |
| Dec 2009 | $18.57 M(+126.0%) | $4.20 M(-24.4%) | $18.57 M(+18.2%) |
| Sep 2009 | - | $5.56 M(+16.2%) | $15.71 M(+25.2%) |
| Jun 2009 | - | $4.79 M(+19.2%) | $12.55 M(+23.4%) |
| Mar 2009 | - | $4.02 M(+197.9%) | $10.17 M(+23.8%) |
| Dec 2008 | $8.22 M(+43.8%) | $1.35 M(-43.7%) | $8.22 M(+7.1%) |
| Sep 2008 | - | $2.40 M(-0.6%) | $7.67 M(+12.3%) |
| Jun 2008 | - | $2.41 M(+16.9%) | $6.83 M(+16.5%) |
| Mar 2008 | - | $2.06 M(+157.8%) | $5.86 M(-2.9%) |
| Dec 2007 | $5.71 M(-29.5%) | $800.00 K(-48.6%) | $6.04 M(-3.7%) |
| Sep 2007 | - | $1.56 M(+7.8%) | $6.27 M(-3.3%) |
| Jun 2007 | - | $1.45 M(-35.5%) | $6.48 M(-12.2%) |
| Mar 2007 | - | $2.24 M(+117.6%) | $7.39 M(-10.3%) |
| Dec 2006 | $8.11 M(+99.1%) | $1.03 M(-41.9%) | $8.24 M(+3.6%) |
| Sep 2006 | - | $1.77 M(-24.6%) | $7.95 M(+6.8%) |
| Jun 2006 | - | $2.35 M(-23.9%) | $7.45 M(+19.1%) |
| Mar 2006 | - | $3.09 M(+316.0%) | $6.25 M(+53.4%) |
| Dec 2005 | $4.07 M(+35.6%) | $742.00 K(-41.4%) | $4.07 M(+4.2%) |
| Sep 2005 | - | $1.27 M(+9.7%) | $3.91 M(+23.3%) |
| Jun 2005 | - | $1.15 M(+26.5%) | $3.17 M(+5.7%) |
| Mar 2005 | - | $912.00 K(+58.3%) | $3.00 M(-0.2%) |
| Dec 2004 | $3.00 M(-16.5%) | $576.00 K(+9.3%) | $3.00 M(+3.2%) |
| Sep 2004 | - | $527.00 K(-46.3%) | $2.91 M(-5.6%) |
| Jun 2004 | - | $982.00 K(+6.9%) | $3.08 M(+0.4%) |
| Mar 2004 | - | $919.00 K(+90.7%) | $3.07 M(-14.6%) |
| Dec 2003 | $3.60 M(+105.4%) | $482.00 K(-31.2%) | $3.60 M(+15.5%) |
| Sep 2003 | - | $701.00 K(-27.8%) | $3.12 M(-2.3%) |
| Jun 2003 | - | $971.00 K(-32.8%) | $3.19 M(+10.2%) |
| Mar 2003 | - | $1.44 M(<-9900.0%) | $2.89 M(+65.2%) |
| Dec 2002 | $1.75 M(+135.2%) | -$1000.00(-100.1%) | $1.75 M(-3.4%) |
| Sep 2002 | - | $774.00 K(+14.3%) | $1.81 M(+50.8%) |
| Jun 2002 | - | $677.00 K(+124.2%) | $1.20 M(+56.3%) |
| Mar 2002 | - | $302.00 K(+403.3%) | $769.00 K(-10.4%) |
| Dec 2001 | $745.00 K(+53.6%) | $60.00 K(-63.2%) | $858.00 K(-20.7%) |
| Sep 2001 | - | $163.00 K(-33.2%) | $1.08 M(+12.9%) |
| Jun 2001 | - | $244.00 K(-37.6%) | $958.50 K(+36.3%) |
| Mar 2001 | - | $391.00 K(+37.8%) | $703.10 K(+44.9%) |
| Dec 2000 | $485.00 K(-123.5%) | $283.80 K(+614.9%) | $485.10 K(+141.0%) |
| Sep 2000 | - | $39.70 K(-448.2%) | $201.30 K(+24.6%) |
| Jun 2000 | - | -$11.40 K(-106.6%) | $161.60 K(-6.6%) |
| Mar 2000 | - | $173.00 K(-136.5%) | $173.00 K(-136.5%) |
| Dec 1999 | -$2.06 M(+167.8%) | - | - |
| Mar 1999 | - | -$474.00 K | -$474.00 K |
| Dec 1998 | -$771.00 K(-75.4%) | - | - |
| Dec 1997 | -$3.14 M(-805.2%) | - | - |
| Dec 1996 | $445.00 K | - | - |
FAQ
- What is Medifast annual earnings before interest & taxes?
- What is the all time high annual EBIT for Medifast?
- What is Medifast annual EBIT year-on-year change?
- What is Medifast quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Medifast?
- What is Medifast quarterly EBIT year-on-year change?
- What is Medifast TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Medifast?
- What is Medifast TTM EBIT year-on-year change?
What is Medifast annual earnings before interest & taxes?
The current annual EBIT of MED is $126.40 M
What is the all time high annual EBIT for Medifast?
Medifast all-time high annual earnings before interest & taxes is $216.24 M
What is Medifast annual EBIT year-on-year change?
Over the past year, MED annual earnings before interest & taxes has changed by -$58.36 M (-31.59%)
What is Medifast quarterly earnings before interest & taxes?
The current quarterly EBIT of MED is $2.11 M
What is the all time high quarterly EBIT for Medifast?
Medifast all-time high quarterly earnings before interest & taxes is $61.41 M
What is Medifast quarterly EBIT year-on-year change?
Over the past year, MED quarterly earnings before interest & taxes has changed by +$9.98 M (+126.74%)
What is Medifast TTM earnings before interest & taxes?
The current TTM EBIT of MED is $10.85 M
What is the all time high TTM EBIT for Medifast?
Medifast all-time high TTM earnings before interest & taxes is $218.49 M
What is Medifast TTM EBIT year-on-year change?
Over the past year, MED TTM earnings before interest & taxes has changed by -$23.40 M (-68.33%)